Non‑denatured Protein Precast Gel segmentation by type classifies the product into four mutually exclusive categories that shape the market’s revenue composition. Standard‑density polyacrylamide gels, representing roughly 45 % of sales, are preferred for routine electrophoresis where uniform pore size ensures reproducible migration of native proteins. Gradient‑density gels, accounting for 30 %, provide a continuous pore‑size gradient that resolves a broader molecular‑weight range, attracting users with complex sample mixtures. Thin‑layer formats, 15 % of the market, are optimized for high‑throughput screening because their reduced thickness shortens run time while preserving native conformation. Finally, special‑buffer gels—incorporating proprietary buffering agents such as Tris‑MES or MOPS—capture the remaining 10 % and are deployed in applications demanding precise pH control or enhanced protein stability. Each type imposes distinct manufacturing tolerances and cost structures; for example, gradient gels require additional casting steps, inflating unit price, whereas thin‑layer gels benefit from lower material consumption. Consequently, the type‑based taxonomy directly informs pricing strategies and profit margins across the Non‑denatured Protein Precast Gel market.
